In Vitro Studies of Netilmicin, a New Aminoglycoside Antibiotic

Netilmicin, a semisynthetic derivative of sisomicin, was tested in vitro against 600 clinical bacterial isolates. At a concentration of 1.56 μg/ml, over 90% of gram-negative bacilli were inhibited. Netilmicin was substantially more active against isolates of Serratia marcescens and Enterobacter spp....

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Stewart, Dorothy, Bodey, Gerald P., LeBlanc, Barbara
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1977
Assuntos:	Physiological Effects and Microbial Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352121/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/879746/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.11.6.1017
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!